These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 36893168)
61. Cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine. Luo A; Oakley A Australas J Dermatol; 2022 Aug; 63(3):e247-e250. PubMed ID: 35607272 [TBL] [Abstract][Full Text] [Related]
62. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk. Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744 [TBL] [Abstract][Full Text] [Related]
63. Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine-a case report. Consoli S; Dono F; Evangelista G; D'Apolito M; Travaglini D; Onofrj M; Bonanni L Neurol Sci; 2022 Feb; 43(2):767-770. PubMed ID: 34807361 [TBL] [Abstract][Full Text] [Related]
64. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022. Hause AM; Baggs J; Marquez P; Abara WE; Olubajo B; Myers TR; Su JR; Thompson D; Gee J; Shimabukuro TT; Shay DK MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(9):347-351. PubMed ID: 35239637 [TBL] [Abstract][Full Text] [Related]
65. Parsonage-Turner syndrome following COVID-19 vaccination and review of the literature. Chua MMJ; Hayes MT; Cosgrove R Surg Neurol Int; 2022; 13():152. PubMed ID: 35509574 [TBL] [Abstract][Full Text] [Related]
66. COVID-19 vaccination-related small vessel vasculitis with multiorgan involvement. Kim Y; Kang J; Lee SG; Kim GT Z Rheumatol; 2022 Aug; 81(6):509-512. PubMed ID: 35587834 [TBL] [Abstract][Full Text] [Related]
67. Safety of COVID-19 Pfizer-BioNtech (BNT162b2) mRNA vaccination in adolescents aged 12-17 years: A systematic review and meta-analysis. Katoto PDMC; Brand AS; Byamungu LN; Tamuzi JL; Mahwire TC; Kitenge MK; Wiysonge CS; Gray G Hum Vaccin Immunother; 2022 Nov; 18(6):2144039. PubMed ID: 36367429 [TBL] [Abstract][Full Text] [Related]
68. Cutaneous lupus-erythematosus-like reaction arising after COVID-19 vaccination. Rose C; Apgar R; Green M J Cutan Pathol; 2022 Nov; 49(11):943-946. PubMed ID: 35754159 [TBL] [Abstract][Full Text] [Related]
70. Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022. Klein NP; Stockwell MS; Demarco M; Gaglani M; Kharbanda AB; Irving SA; Rao S; Grannis SJ; Dascomb K; Murthy K; Rowley EA; Dalton AF; DeSilva MB; Dixon BE; Natarajan K; Stenehjem E; Naleway AL; Lewis N; Ong TC; Patel P; Konatham D; Embi PJ; Reese SE; Han J; Grisel N; Goddard K; Barron MA; Dickerson M; Liao IC; Fadel WF; Yang DH; Arndorfer J; Fireman B; Griggs EP; Valvi NR; Hallowell C; Zerbo O; Reynolds S; Ferdinands J; Wondimu MH; Williams J; Bozio CH; Link-Gelles R; Azziz-Baumgartner E; Schrag SJ; Thompson MG; Verani JR MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(9):352-358. PubMed ID: 35239634 [TBL] [Abstract][Full Text] [Related]
71. Reactions following Pfizer-BioNTech COVID-19 mRNA vaccination and related healthcare encounters among 7,077 children aged 5-11 years within an integrated healthcare system. Malden DE; Gee J; Glenn S; Li Z; Mercado C; Ogun OA; Kim S; Lewin BJ; Ackerson BK; Jazwa A; Weintraub ES; McNeil MM; Tartof SY Vaccine; 2023 Jan; 41(2):315-322. PubMed ID: 36351861 [TBL] [Abstract][Full Text] [Related]
77. Parsonage-Turner syndrome after SARS-CoV-2 vaccination: A case report. Öncel A; Coşkun E Turk J Phys Med Rehabil; 2022 Sep; 68(3):418-421. PubMed ID: 36475106 [TBL] [Abstract][Full Text] [Related]